The need for urogenital tract monitoring in COVID-19

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2, which invades a cell through binding to the ACE2 receptor and TMPRSS2 priming. Patients with severe disease predominantly present with pneumonia-related symptoms. However, evidence suggests that COVID-1...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Urology 2020-06, Vol.17 (6), p.314-315
Hauptverfasser:	Wang, Shangqian, Zhou, Xiang, Zhang, Tongtong, Wang, Zengjun
Format:	Artikel
Sprache:	eng
Schlagworte:	631/326/596/4130 692/4025/2021 692/4025/2768 Acute Kidney Injury - diagnosis Acute Kidney Injury - metabolism Acute Kidney Injury - virology Angiotensin-Converting Enzyme 2 Betacoronavirus - metabolism Comment Coronavirus Infections - diagnosis Coronavirus Infections - metabolism Coronaviruses COVID-19 Health aspects Humans Male Medical colleges Medicine Medicine & Public Health Pandemics Peptidyl-Dipeptidase A - metabolism Pneumonia, Viral - diagnosis Pneumonia, Viral - metabolism SARS-CoV-2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Testis - metabolism Testis - pathology Testis - virology Urogenital System - metabolism Urogenital System - pathology Urogenital System - virology Urology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2, which invades a cell through binding to the ACE2 receptor and TMPRSS2 priming. Patients with severe disease predominantly present with pneumonia-related symptoms. However, evidence suggests that COVID-19 infection also has implications for the urogenital tract. Thus, urogenital organs should be considered when treating COVID-19.
ISSN:	1759-4812 1759-4820
DOI:	10.1038/s41585-020-0319-7